Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study123
Cited by (0)
- 1
From the Unit of Nutrition Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Idibell, Barcelona, Spain (GB, AA, LL, PJ, and CAG); the National Institute for Public Health and the Environment, Bilthoven, Netherlands (HBB-d-M); the Molecular and Nutritional Epidemiology Unit, CSPO–Scientific Institute of Tuscany, Florence, Italy (DP); the German Institute of Human Nutrition, Potsdam-Rehbücke, Germany (HB); the Institute of Molecular Pathology and Immunology of the University of Porto and Medical Faculty/HS João, Porto, Portugal (FC); the Department of Preventive & Predictive Medicine, Nutritional Epidemiology Unit, National Institute of Tumori, Milan, Italy (VK); the University of Torino, Torino, Italy (CS); the Cancer Registry, Azienda Ospedaliera “Civile M.P. Arezzo”, Ragusa, Italy (RT); the Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy (SP); the Department of Human Pathology and Oncology, University of Florence, Florence, Italy (GN); the Department of Surgery, Malmö University Hospital, Sweden, (JM and SR); the Department of Nutritional Research, University of Umeå, Umeå, Sweden (IJ); the Department of Medical Biosciences, University of Umeå, Umeå, Sweden (RS); the Andalusian School of Public Health, Granada, Spain, and CIBER de Epidemiología y Salud Pública, Spain (M-JS); the Department of Public Health of Guipuzkoa, San Sebastian, Spain (MD); the Public Health Institute of Navarra, Pamplona, Spain (AB); the Epidemiology Department, Health Council of Murcia, and CIBER de Epidemiología y Salud Pública, Murcia, Spain (CN); the Public Health and Health Planning Directorate, Asturias, Spain (JRQ); the Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom (NEA and TJK); the MRC Dunn Human Nutrition Unit, & MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival and the Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (SB); the Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany (RK); the Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark (KO and MJ); the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (AO and A Tjønneland); the Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Netherlands (PHMP and MEN); the National Institute for Public Health and the Environment, Bilthoven, Netherlands (MCO); INSERM, Institut Gustave Roussy, Villejuif, France (FC-C SM, and M-CB-R); the Department of Hygiene and Epidemiology, University of Athens Medical School, Greece and Hellenic Health Foundation Athens, Greece (A Trichopoulou and PL); the Department of Epidemiology, Harvard School of Public Health, Boston, MA (DT); the Institute of Community Medicine, University of Tromso, Tromso, Norway (EL); the International Agency for Research on Cancer, Lyon, France (EC PB, and MJ); and the Faculty of Medicine, Division of Epidemiology, Public Health and Primary Care, Imperial College London, London, United Kingdom (ER DR, and TM).
- 2
Supported by the European Commission FP5 project (QLG1-CT-2001-01049). The EPIC study was funded by “Europe Against Cancer” Programme of the European Commission (SANCO); ISCIII of the Spanish Ministry of Health (RETICC DR06/0020); Ligue contre le Cancer (France); Société 3M (France); Mutuelle Générale de l’Education Nationale; Institut National de la Santé et de la Recherche Médicale (INSERM); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health (RTICCC; C03/10); the participating regional governments and institutions of Spain; Cancer Research United Kingdom; Medical Research Council, United Kingdom; the Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; the Wellcome Trust, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Dutch Ministry of Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch Zorg Onderzoek Nederland; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society. Some authors are partners of ECNIS, a network of excellence of the EC (6FP contract 513943).
- 3
Address correspondence to CA González, Unit of Nutrition Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Idibell, Barcelona, Spain. E-mail: [email protected].